Key result
Post-1972 radiation therapy improvements linked to a ~74% lower risk of nonacute MI cardiac death.
Systematic Review
Effect estimate: HR 5.3 (95% CI null)
p-value: p=null
Lifelong cardiology follow-up and screening for heart disease are essential for patients with a history of radiation exposure due to the wide range of potential delayed cardiovascular complications.
Supports refined radiation techniques to reduce cardiac mortality in cancer patients; leaves open prospective validation in current cohorts.
The cardiovascular sequelae of radiation exposure are an important cause of morbidity and mortality following radiation therapy for cancer, as well as after exposure to radiation after atomic bombs or nuclear accidents. In the United States, most of the data on radiation-induced heart disease (RIHD) come from patients treated with radiation therapy for Hodgkin disease and breast cancer. Additionally, people exposed to radiation from the atomic bombs in Hiroshima and Nagasaki, Japan, and the Chernobyl, Ukraine, nuclear accident have an increased risk of cardiovascular disease. The total dose of radiation, as well as the fractionation of the dose, plays an important role in the development of RIHD. All parts of the heart are affected, including the pericardium, vasculature, myocardium, valves, and conduction system. The mechanism of injury is complex, but one major mechanism is injury to endothelium in both the microvasculature and coronary arteries. This likely also contributes to damage and fibrosis within the myocardium. Additionally, various inflammatory and profibrotic cytokines contribute to injury. Diagnosis and treatment are not significantly different from those for conventional cardiovascular disease; however, screening for heart disease and lifelong cardiology follow-up is essential in patients with past radiation exposure.
No takes yet. Share an insight, caveat, or question.
Finch et al. (2014) conducted a systematic review in radiation-induced heart disease. Radiation Therapy vs. Patients not receiving radiation therapy was evaluated on Cardiovascular mortality due to radiation-induced heart disease (HR 5.3, 95% CI null, p=null).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: